Analysis of Customer Satisfaction relating to the vaccination campaign aimed at extremely vulnerable people in the Asl of Latina. / Analisi della Customer Satisfaction relativa la campagna vaccinale rivolta alle persone estremamente vulnerabili nella Asl di Latina.

INTRODUCTION: Customer Satisfaction is a tool for assessing the effectiveness and efficiency of the service offered and related corrective measures to improve the quality of services provided by hospitals Collection and analysis of data regarding customer satisfaction during the vaccination campaign was estremely important. METHOD: A specific analisys on extremely vulnerable people during the vaccination campaign. An observational study was conducted through a survey on a List of extremely vulnerable people provided by specialists to the Medical Management. RESULTS: There was good feedback with the return of most of the questionnaires administered and above all a good degree of satisfaction and protection on the part of the user. CONCLUSION: The analysis carried out found that by placing the centrality of the person, "patient-oriented" in the foreground, with listening, the "taken care of", creates an empathic relationship between the healthcare professional and the user. This humanization makes the user feel satisfied and above all protected even during such a particular path as vaccination.

[Antitetanus vaccination: benefits and risks]. / Vaccinazione antitetanica: benefici e rischi.

The significant reduction of the cases of tetanus in the years led to an increased perception of risk associated with vaccination, which, like any medical procedure, entails the possibility of adverse reactions. Although the reviews of the literature show that the tetanus vaccine is implicated as responsible for serious adverse events, the neurological complications associated with it are extremely rare, as confirmed also by the small number of cases reported in the literature. It's necessary that all events temporally associated with vaccination are properly investigated and brought to the attention of healthcare workers and citizens, in order to establish an early treatment, which in most cases leads to complete recovery.

[Epidemiology and prevention of hepatitis A and B in developing countries]. / Attualità in epidemiologia e prevenzione delle epatiti A e B nei Paesi in via di sviluppo.

Viral hepatitis A and B are serious public health problems all over the world. Effective prophylactic measures and improvement in the hygienic and sanitary conditions have considerably modified the diseases trend, characterized by high prevalence levels in developing countries. In this paper the epidemiology of hepatitis A and B is reviewed, focused on endemic areas, on the basis of data collected from local and international studies in order to evaluate prevention strategies for both local population and travelers.

[Survey among female university students on HPV infection epidemiology and prevention]. / Conoscenze sull'infezione da HPV a due anni dall'inizio della campagna vaccinale: indagine tra le studentesse dell'Università di Roma Tor Vergata.

Human papilloma virus (HPV) is one of the most common sexually transmitted infections. The vaccine has the maximum benefit when given before starting sexual activity and its efficacy is proved also in sexually active women in which the incidence of the infection is higher. In 2010 a questionnaire on HPV was administered to 299 female students of University of Rome Tor Vergata. The results compared with those obtained in a similar 2007-08 survey, and with international data, showed that knowledge about HPV is still low, with a negative impact on the acceptance of specific preventive measures.

Hepatitis A: Epidemiology and prevention in developing countries.

Hepatitis A is the most common form of acute viral hepatitis in the world. Major geographical differences in endemicity of hepatitis A are closely related to hygienic and sanitary conditions and other indicators of the level of socioeconomic development. The anti-hepatitis A virus (HAV) seroprevalence rate is presently decreasing in many parts of the world, but in less developed regions and in several developing countries, HAV infection is still very common in the first years of life and seroprevalence rates approach 100%. In areas of intermediate endemicity, the delay in the exposure to the virus has generated a huge number of susceptible adolescents and adults and significantly increased the average age at infection. As the severity of disease increases with age, this has led to outbreaks of hepatitis A. Several factors contribute to the decline of the infection rate, including rising socioeconomic levels, increased access to clean water and the availability of a hepatitis A vaccine that was developed in the 1990s. For populations with a high proportion of susceptible adults, implementing vaccination programs may be considered. In this report, we review available epidemiological data and implementation of vaccination strategies, particularly focusing on developing countries.